AI assistant
Sending…
Altimmune, Inc. — Director's Dealing 2023
Mar 27, 2023
33207_dirs_2023-03-27_bb5f5e3a-5529-4403-9d6b-905fa856a04c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2023-03-23
Reporting Person: Sohn Catherine A. (Director)
More from Altimmune, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Capital/Financing Update
2026
Apr 22
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 17
Proxy Solicitation & Information Statement
2026
Mar 17
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 6